Completed OBSERVATIONAL NCT01246778

Sunitinib and Atrial Trabeculae Contractility (SCAR)

The Influence of Sunitinib on Contractility of Human Atrial Trabeculae

Sponsor: Radboud University Medical Center

Conditions Cardiotoxicity Heart Failure Ischemia

Updated 11 times since 2017 Last updated: Apr 30, 2014 Started: Nov 30, 2010 Primary completion: Apr 30, 2014 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01246778, this observational or N/A phase trial focuses on Cardiotoxicity and Heart Failure and remains completed. Sponsored by Radboud University Medical Center, it has been updated 11 times since 2010, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Mar 2022 — Jul 2024 [monthly]

Completed
Dec 2021 — Mar 2022 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed

▶ Show 6 earlier versions

Nov 2020 — Jan 2021 [monthly]

Completed
Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Nov 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Radboud University Medical Center

Data source: Radboud University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nijmegen, Netherlands